Regulatory status of pancreatic enzyme preparations.
作者信息
Rheinstein P H
出版信息
JAMA. 1990 May 9;263(18):2491-2.
PMID:2329638
Abstract
摘要
相似文献
1
Regulatory status of pancreatic enzyme preparations.胰酶制剂的监管状况。
JAMA. 1990 May 9;263(18):2491-2.
2
Treatment failure after substitution of generic pancrelipase capsules.
JAMA. 1990 Dec 26;264(24):3148-9. doi: 10.1001/jama.1990.03450240050035.
3
[Pancreatic enzymes--substitution preparations].[胰酶——替代制剂]
Z Allgemeinmed. 1972 Dec 20;48(35):1641-4.
4
5
[In vitro studies of pancreatic enzyme substitution].[胰腺酶替代的体外研究]
Dtsch Med Wochenschr. 1987 Sep 25;112(39):1498-502. doi: 10.1055/s-2008-1068278.
6
7
Correction of malnutrition and maldigestion with enzyme supplementation in patients with surgical suppression of exocrine pancreatic function.对外分泌胰腺功能受到手术抑制的患者补充酶来纠正营养不良和消化功能不良。
Surg Gynecol Obstet. 1988 Dec;167(6):485-92.
8
Comparative in vitro enzyme activities of five commercially available pancreatic supplements.五种市售胰腺补充剂的体外酶活性比较
N Z Med J. 1982 Jun 23;95(710):424-5.
9
Solubility of oral pancreatic enzyme supplement capsules in biological fluids.口服胰酶补充剂胶囊在生物流体中的溶解度。
Lancet. 1980 Sep 6;2(8193):544. doi: 10.1016/s0140-6736(80)91877-2.
10
Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study.新配方胰酶肠溶胶囊治疗 7 至 11 岁儿童胰腺外分泌功能不全和囊性纤维化的疗效和耐受性：一项多中心、随机、双盲、安慰剂对照、两周期交叉、优效性研究。
Clin Ther. 2010 Jan;32(1):89-103. doi: 10.1016/j.clinthera.2010.01.012.
Zotero 插件